ArticleMultiple sclerosis and related disorders2022

SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine.

Masoud Etemadifar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.